EcDNA-borne structural variants drive oncogenic fusion transcript amplification

Extrachromosomal DNA (ecDNA) amplifications are key drivers of human cancers. Here, we show that ecDNAs are major platforms for generating and amplifying oncogene fusion transcripts across diverse cancer types. By integrating analysis of whole-genome and transcriptome sequences from tumor samples and cancer cell lines of a wide variety of tissue types, we reveal that ecDNAs have the highest rate of oncogene fusion events of any copy-number alteration. Focusing on the most common ecDNA fusion hotspot, we find that fusion of the 5' end of the long noncoding RNA gene, PVT1-with exon 1 joined to diverse 3' partners-confers increased RNA stability, potentially via an SRSF1-dependent mechanism, and enhances MYC-dependent transcription and cancer cell survival. These results demonstrate that ecDNA fosters genome instability and frequent oncogene fusion formation in cancer.

Authors

Institutions

Publication Details

Journal
Cell
Published
2026-01-07
DOI
https://doi.org/10.1016/j.cell.2025.12.009
Citations
1
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
24.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EcDNA-borne structural variants drive oncogenic fusion transcript amplification

Dean W. Felsher, Shu Zhang, Vishnupriya Kanakaveti, Quanming Shi et al.
1 citations
Cell
Cancer Genomics and Diagnostics
24.82
article

EcDNA-borne structural variants drive oncogenic fusion transcript amplification

Dean W. Felsher, Shu Zhang, Vishnupriya Kanakaveti, Quanming Shi, Suhas Srinivasan, Luke A. Gilbert, Ellis J. Curtis, Paul S. Mischel, Ivy Tsz-Lo Wong, H J Chang, Julia A. Belk, Hyerim Yi, Mariam Jamal‐Hanjani, Y. Zhao, Xiaowei Yan, Fei Liang, Katerina Kraft, Chris Bailey, King L. Hung, Jason Swinderman, Matthew G. Jones, Yanbo Wang, Aarohi Bhargava-Shah, Vineet Bafna, Simon K. Pritchard, Rui Li, Jens Luebeck, Kabir S. Mahajan
article en
1 citations

Abstract

Extrachromosomal DNA (ecDNA) amplifications are key drivers of human cancers. Here, we show that ecDNAs are major platforms for generating and amplifying oncogene fusion transcripts across diverse cancer types. By integrating analysis of whole-genome and transcriptome sequences from tumor samples and cancer cell lines of a wide variety of tissue types, we reveal that ecDNAs have the highest rate of oncogene fusion events of any copy-number alteration. Focusing on the most common ecDNA fusion hotspot, we find that fusion of the 5' end of the long noncoding RNA gene, PVT1-with exon 1 joined to diverse 3' partners-confers increased RNA stability, potentially via an SRSF1-dependent mechanism, and enhances MYC-dependent transcription and cancer cell survival. These results demonstrate that ecDNA fosters genome instability and frequent oncogene fusion formation in cancer.

CellVol. 189(3)
University of California, San Francisco (US), The Francis Crick Institute (GB), University of California San Diego (US), Stanford Medicine (US), Pediatrics and Genetics (US), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB), Stanford University (US)
Openalex Percentile: Top 3%
Cancer Genomics and Diagnostics
24.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.